NAT-BOSENTAN
Identification of Nat-Bosentan
| No description |
Google image searchProduct monograph
Active ingredient
bosentan (bosentan monohydrate), 125 MG
DIN: 02467992
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 30-APR-2020
ATC:
- C02 — ANTIHYPERTENSIVES (ATC, ATC/DDD, )
- C02K — OTHER ANTIHYPERTENSIVES (ATC, ATC/DDD)
- C02KX — Other antihypertensives (ATC, ATC/DDD)
- C02KX01 — BOSENTAN (ATC/DDD)
Reference brand drug: Tracleer
